Analytics focus New York City based analytics company specializing in large raw biomedical datasets (EEG, MRI, CT, genomics) offering cloud-based analysis to physicians and researchers, presenting a potential value proposition for data-rich clinical and translational research engagements.

Sizable funding Revenue in the low-to-mid multi-millions with external funding of about two million, indicating early-stage growth momentum and potential for scale partnerships or pilot programs with healthcare institutions and research centers.

Tech stack fit Cloud and web-based infrastructure leveraging Microsoft Azure, Windows Server, PHP, Bootstrap, jQuery and Google services, suggesting a readiness for integration with hospital IT ecosystems and analytics workflows.

SMB to mid-market positioning Headcount near zero to one but revenue signals, aligning with a nimble, boutique analytics vendor that could scale through targeted pilots with mid-sized hospitals, academic medical centers, or specialty imaging groups.

Competitive landscape Operating in a market with established players like QIAGEN, Thermo Fisher, and Bruker; potential sales opportunities exist in differentiating through domain-specific biomedical analytics, scalable cloud-based analysis, and rapid time-to-insight for neuroimaging and genomics data.